Quality Assurance & Quality Control
Integrated Approach to Pharmaceutical Excellence
Quality Assurance (QA)
Independent oversight for compliance and excellence
Quality Assurance at Cerata Pharmaceuticals LLP functions independently across development laboratories, manufacturing units, and quality control operations. QA oversees a comprehensive QMS aligned with WHO-GMP and cGMP guidelines, ensuring controlled, compliant, and reproducible manufacturing.
Core QA Responsibilities:
- Integrated QMS aligned with WHO-GMP and cGMP guidelines
- Independent QA oversight across manufacturing and laboratories
- End-to-end batch traceability and lifecycle management
- Vendor qualification and contract laboratory assessment
- Support for DMF and regulatory submission documentation for global markets
- Data integrity governance and audit readiness
- Change management, deviation investigation, and CAPA implementation
- Process and cleaning validation oversight
- Quality risk management and lifecycle control
Our QA systems are designed to exceed regulatory expectations, ensuring consistent product integrity, controlled manufacturing environments, and sustainable quality performance.
Quality Control (QC)
Analytical excellence for product verification
Cerata Pharmaceuticals LLP operates advanced, fully in-house Quality Control laboratories supporting Steroid, Hormone, Oncology, and Peptide API manufacturing. QC activities cover the complete product lifecycle, including raw materials, in-process samples, intermediates, finished APIs, cleaning verification, water systems, and environmental monitoring.
Core QC Responsibilities:
- Raw material qualification and vendor approval programs
- In-process control and critical parameter monitoring
- Intermediate and finished API testing and release
- Validated analytical methods ensuring accuracy and reproducibility
- Stability studies supporting shelf life and regulatory filings as per ICH guidelines
- Cleaning verification and cross-contamination control
- Water system testing and environmental monitoring
- Out-of-specification (OOS) investigation
- Compliance with pharmacopoeial standards (USP, EP, JP)
Our QC teams ensure analytical reliability and data accuracy, providing the scientific foundation for product quality and regulatory compliance.
Analytical Infrastructure
State-of-the-Art Quality Control Laboratories
Commitment to Analytical Excellence
- All analytical methods are fully validated as per regulatory guidelines
- Routine calibration and qualification of analytical instruments
- Continuous stability monitoring under ICH-compliant conditions
- Strict adherence to global QA/QC and data integrity standards
- Ensures batch-to-batch consistency and regulatory confidence
This centralized QA/QC system enables Cerata to consistently deliver high-quality APIs with proven reliability and compliance for global pharmaceutical markets.
Quality Focus by API Category
Specialized Quality Control Strategies for Different Therapeutic Classes
Steroid & Hormone APIs
Steroid and Hormone API manufacturing demands precise control over chemistry, dosage uniformity, and impurity profiles. Cerata applies specialized quality control strategies to ensure consistent quality and safety of endocrine-active molecules.
Oncology APIs
Oncology APIs are manufactured under enhanced quality and safety frameworks due to their high potency and cytotoxic nature, requiring stringent controls and specialized handling.
Peptide APIs
Peptide APIs require molecular-level accuracy and sequence fidelity, supported by advanced analytical and process controls to ensure purity and biological activity.
Regulatory Approvals & Certifications
Compliance with Global Standards
Certifications & Standards
Audits & Compliance
Partnership Enablement
This regulatory-driven manufacturing approach enables seamless customer qualification, efficient technology transfer, and long-term commercial partnerships with multinational pharmaceutical companies.
Stability Studies
Ensuring Product Integrity Throughout Shelf Life
ICH-Compliant Stability Chambers
State-of-the-art chambers with 24/7 continuous monitoring for long-term, intermediate, and accelerated stability studies
Comprehensive Testing
Stability evaluation of Steroid, Hormone, Oncology, and Peptide APIs with stability indicating analytical methods
Regulatory Support
Stability data support for regulatory filings, DMFs, and customer submissions
Stability Study Types:
Quality Risk Management & Product Quality Reviews
Proactive Quality Assurance for Continuous Improvement
Quality Risk Management
Aligning with ICH Principles
Cerata follows a structured, risk-based Quality Risk Management approach aligned with ICH principles. Process design, scale-up, and commercial manufacturing are supported by continuous risk assessment to identify, evaluate, and control critical quality attributes and process parameters.
Changes introduced during development or lifecycle management are treated as controlled opportunities for process optimization, ensuring enhanced process understanding without compromising product quality or compliance.
Product Quality Reviews (PQR)
Comprehensive Quality Assessment
Comprehensive Product Quality Reviews are conducted for Steroid, Hormone, Oncology, and Peptide APIs to assess manufacturing consistency, analytical trends, stability performance, and process robustness.
PQR Includes:
- Trend analysis of batch manufacturing and analytical data
- Evaluation of critical quality parameters
- Review of deviations, complaints, and corrective actions
- Recommendations for continuous improvement
These reviews reinforce Cerata's commitment to consistent quality, regulatory transparency, and continuous improvement.
Self-Inspection & Our Strengths
Audit Readiness and Quality Excellence
Self-Inspection & Audit Readiness
A structured self-inspection program, managed by Quality Assurance, ensures continuous adherence to cGMP requirements. Annual audit plans are executed by trained, cross-functional teams, with clearly defined corrective and preventive actions tracked to closure.
Proven Audit Success
Cerata's manufacturing facilities have successfully undergone multiple customer audits covering Quality, EHS, and sustainability, reinforcing confidence among multinational pharmaceutical partners.
This disciplined and science-driven quality approach enables Cerata Pharmaceuticals LLP to consistently deliver high-purity, compliant, and reliable APIs for regulated and semi-regulated pharmaceutical markets worldwide.
Our Strength
Fully In-House QC
Complete analytical testing capabilities within our facilities
API-Specific Quality Controls
Tailored controls for Steroid, Hormone, Oncology, and Peptide products
Risk-Based Quality Management
Aligned with global guidelines and best practices
Strong Audit Readiness
Regulatory transparency and audit-ready documentation
Exceeding Standards
Quality standards set internally above minimum regulatory requirements